Drugs / Multiple Electrolytes Injection Ⅱ
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06076590 | Nov 2021 → May 2023 | acquired aneurysmal subarachnoid hemorrhage | Capital Medical University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | multiple electrolytes injection II | “Impact of Multiple Electrolytes Injection Ⅱ and Saline on Hyperchloremia in Patients With Aneurysmal Subarachnoid Hemorrhage:a Pilot Study” NCT06076590 ↗1“Experimental group drugs: Multiple Electrolytes Injection(II) Manufacturer: B.Braun Melsungen AG” NCT06076590 ↗ |